"Executive Summary NGS-Based RNA-Sequencing Market :

Global NGS-based RNA-sequencing market size was valued at USD 4.21 billion in 2024 and is projected to reach USD 17.96 billion by 2032, with a CAGR of 19.90% during the forecast period of 2025 to 2032

NGS-Based RNA-Sequencing Market research report genuinely attempts to determine the impact of buyers, substitutes, new entrants, competitors, and suppliers on the market. Besides, the market report gives insights into revenue growth and sustainability initiative. With the global market data provided in this report, it has become easy to gain global perspective for the international business. The market report also performs study on production capacity, consumption, import and export for all major regions across the globe. An international NGS-Based RNA-Sequencing Market report aids to establish correlative relationship between the product brand and consumers’ needs and preferences.

The superior NGS-Based RNA-Sequencing Market report encompasses various segments related to industry and market with thorough research and analysis. All the data, statistics and information is backed up by well established analysis tools which include SWOT analysis and Porter’s Five Forces analysis. The report covers several market dynamics and also estimates the growth rate and the market value based on market dynamics and growth inducing factors. The data and information of the report not only helps business make data-driven decisions but also guarantees maximum return on investment (ROI). Clients can reveal best opportunities to be successful in the market with an excellent practice models and method of research used while generating a reliable NGS-Based RNA-Sequencing Market report.

Discover the latest trends, growth opportunities, and strategic insights in our comprehensive NGS-Based RNA-Sequencing Market report. Download Full Report: https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-market

NGS-Based RNA-Sequencing Market Overview

**Segments**

- **By Product & Services**
- Sample Preparation
- Sequencing Platforms
- Consumables
- Data Analysis, Storage, and Management (Bioinformatics)
- **By Technology**
- Sequencing By Synthesis (SBS)
- Ion Semiconductor Sequencing
- Sequencing By Ligation (SBL)
- Pyrosequencing
- Single-Molecule Real-time (SMRT) Sequencing
- Nanopore Sequencing
- **By Workflow**
- Pre-sequencing
- Sequencing
- Data Analysis
- **By Application**
- De Novo Transcriptome Assembly
- Quantification of Gene Expression
- Variant Calling
- Antisense RNA Expression
- miRNA Expression Profiling
- **By End User**
- Hospitals & Healthcare Institutions
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes

The global NGS-based RNA-sequencing market is segmented based on various key factors, including Product & Services, Technology, Workflow, Application, and End User. Under Product & Services, the market is categorized into Sample Preparation, Sequencing Platforms, Consumables, and Data Analysis, Storage, and Management (Bioinformatics). In terms of Technology, the market is divided into Sequencing By Synthesis (SBS), Ion Semiconductor Sequencing, Sequencing By Ligation (SBL), Pyrosequencing, Single-Molecule Real-time (SMRT) Sequencing, and Nanopore Sequencing. The Workflow segment includes Pre-sequencing, Sequencing, and Data Analysis. Furthermore, the Application segment comprises De Novo Transcriptome Assembly, Quantification of Gene Expression, Variant Calling, Antisense RNA Expression, and miRNA Expression Profiling. Lastly, the End User segment covers Hospitals & Healthcare Institutions, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes.

**Market Players**

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- PerkinElmer Inc.
- QIAGEN
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- GENEWIZ
- Macrogen Inc.
- Hamilton Company
- Oxford Nanopore Technologies

Some of the major players in the global NGS-based RNA-sequencing market include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., PerkinElmer Inc., QIAGEN, Eurofins Scientific, F. Hoffmann-La Roche Ltd., GENEWIZ, Macrogen Inc., Hamilton Company, and Oxford Nanopore Technologies. These companies are actively involved in research and development activities, strategic partnerships, and mergers & acquisitions to enhance their market presence and gain a competitive edge in the industry.

https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-marketThe global NGS-based RNA-sequencing market is experiencing significant growth and evolution due to the increasing demand for advanced technologies in the field of genomics research and personalized medicine. One of the key trends shaping this market is the growing adoption of NGS-based RNA-sequencing in various applications such as transcriptome analysis, gene expression profiling, and variant calling. This technology offers higher accuracy, sensitivity, and cost-effectiveness compared to traditional methods, driving its widespread use in research institutions, healthcare facilities, and pharmaceutical companies.

A major factor driving the market growth is the continuous technological advancements in NGS platforms and bioinformatics tools, enabling researchers to generate high-throughput sequencing data with improved efficiency and accuracy. Companies like Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies are at the forefront of innovation in this space, developing cutting-edge sequencing platforms and analysis software to meet the evolving needs of the market. Additionally, the increasing focus on precision medicine and personalized healthcare is expected to further drive the adoption of NGS-based RNA-sequencing technologies globally.

Furthermore, the market is witnessing a surge in strategic collaborations and partnerships among key players to expand their product portfolios and geographic presence. Mergers and acquisitions are also common in the industry as companies aim to strengthen their market position and enhance their competitive edge. For instance, Illumina's acquisition of Pacific Biosciences and Grail Inc. has significantly boosted its portfolio of sequencing technologies and diagnostic solutions.

The COVID-19 pandemic has also acted as a catalyst for the adoption of NGS-based RNA-sequencing technologies, particularly in understanding the genomic characteristics of the virus and developing effective diagnostic and therapeutic solutions. As the focus on precision medicine and genomic research intensifies, the demand for advanced sequencing platforms and bioinformatics tools is expected to continue to rise, further driving the growth of the global NGS-based RNA-sequencing market.

In conclusion, the global NGS-based RNA-sequencing market is poised for substantial growth in the coming years, driven by technological advancements, increasing application in various sectors, and strategic initiatives by key market players. With a growing emphasis on precision medicine and personalized healthcare, NGS-based RNA-sequencing is set to play a crucial role in advancing genomics research and transforming the landscape of molecular biology.The global NGS-based RNA-sequencing market is witnessing a significant surge in growth and evolution driven by various key factors. The rapid adoption of advanced technologies in genomics research and personalized medicine is a primary driver of market expansion. NGS-based RNA-sequencing is increasingly being utilized in diverse applications such as transcriptome analysis, gene expression profiling, and variant calling due to its enhanced accuracy, sensitivity, and cost-effectiveness compared to traditional methods. This trend is fueling the demand for these technologies across research institutions, healthcare facilities, and pharmaceutical companies globally.

Moreover, the continuous technological advancements in NGS platforms and bioinformatics tools are enhancing the efficiency and accuracy of high-throughput sequencing data generation. Leading market players like Illumina, Thermo Fisher Scientific, and Oxford Nanopore Technologies are spearheading innovation in the development of cutting-edge sequencing platforms and analysis software, catering to the evolving needs of the market. The increasing focus on precision medicine and personalized healthcare further propels the adoption of NGS-based RNA-sequencing technologies on a global scale.

Strategic collaborations and partnerships among key industry players are on the rise, aimed at expanding product portfolios and geographical presence. Mergers and acquisitions are also prevalent in the market as companies strive to solidify their market positions and gain a competitive advantage. For example, Illumina's acquisitions of Pacific Biosciences and Grail Inc. have significantly bolstered its offerings of sequencing technologies and diagnostic solutions, showcasing the strategic moves within the industry.

The impact of the COVID-19 pandemic has accelerated the adoption of NGS-based RNA-sequencing technologies, particularly in understanding the genomic characteristics of the virus and developing effective diagnostic and therapeutic solutions. As the emphasis on precision medicine and genomic research grows, the demand for advanced sequencing platforms and bioinformatics tools is projected to continue rising, further stimulating the expansion of the global NGS-based RNA-sequencing market.

In conclusion, the global NGS-based RNA-sequencing market is poised for substantial growth in the foreseeable future, driven by technological innovations, increasing applications across multiple sectors, and strategic initiatives by key market players. The market landscape is evolving rapidly, with NGS-based RNA-sequencing poised to play a pivotal role in advancing genomics research and reshaping the molecular biology domain with its transformative capabilities.

The NGS-Based RNA-Sequencing Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.

Learn More Now: https://www.databridgemarketresearch.com/reports/global-ngs-based-rna-sequencing-market/companies

DBMR Nucleus: Powering Insights, Strategy & Growth

DBMR Nucleus is a dynamic, AI-powered business intelligence platform designed to revolutionize the way organizations access and interpret market data. Developed by Data Bridge Market Research, Nucleus integrates cutting-edge analytics with intuitive dashboards to deliver real-time insights across industries. From tracking market trends and competitive landscapes to uncovering growth opportunities, the platform enables strategic decision-making backed by data-driven evidence. Whether you're a startup or an enterprise, DBMR Nucleus equips you with the tools to stay ahead of the curve and fuel long-term success.

Regional Analysis/Insights

• The NGS-Based RNA-Sequencing Market is analyzed and market size insights and trends are provided by country, component, products, end use and application as referenced above.
• The countries covered in the NGS-Based RNA-Sequencing Market reportare U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
• North America dominatesthe NGS-Based RNA-Sequencing Market because of the region's high prevalence NGS-Based RNA-Sequencing Market
• Asia-Pacific is expectedto witness significant growth. Due to the focus of various established market players to expand their presence and the rising number of surgeries in this particular region.

Browse More Reports:

Global Automotive Engineering Services Market
Global Benzalkonium Chloride Market
Global Braze Alloys Market
Global Cash- in Transit Bags Market
Global Clot Retrievers Market
Global Contact Center Solutions Market
Global Data Warehouse as a Service Market
Global Disposable Peripheral Capillary Oxygen Saturation (SpO2) Sensor Market
Global Emotion Detection and Recognition Market
Global Feed Vitamins and Minerals Market
Global Food Processing and Food Material Handling Equipment Market
Global Glassine and Glass Proof Packaging Market
Global Health Insurance Market
Global Hunter Syndrome Treatment Market
Global Infliximab Market
Global Kiteboarding Equipment Market
Global Logic Semiconductor Market
Global Medical Personal Protective Equipment Market
Global Mobile Apps and Web Analytics Market
Global Neonatal Care Devices Market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Email:- corporatesales@databridgemarketresearch.com

Tag

NGS-Based RNA-Sequencing Market Size, NGS-Based RNA-Sequencing Market Share, NGS-Based RNA-Sequencing Market Trend, NGS-Based RNA-Sequencing Market Analysis, NGS-Based RNA-Sequencing Market Report, NGS-Based RNA-Sequencing Market Growth,  Latest Developments in NGS-Based RNA-Sequencing Market, NGS-Based RNA-Sequencing Market Industry Analysis, NGS-Based RNA-Sequencing Market Key Player, NGS-Based RNA-Sequencing Market Demand Analysis"